17β-Estradiol (E<sub>2</sub>) Upregulates the ERα/SIRT1/PGC-1α Signaling Pathway and Protects Mitochondrial Function to Prevent Bilateral Oophorectomy (OVX)-Induced Nonalcoholic Fatty Liver Disease (NAFLD)

Premature menopause is associated with an increased prevalence of nonalcoholic fatty liver disease (NAFLD). Menopausal hormone therapy (MHT) has been widely used in clinical practice and has the potential to protect mitochondrial function and alleviate NAFLD. After bilateral oophorectomy (OVX), fema...

Full description

Bibliographic Details
Main Authors: Ying Tian, Xinyu Hong, Yuan Xie, Zaixin Guo, Qi Yu
Format: Article
Language:English
Published: MDPI AG 2023-12-01
Series:Antioxidants
Subjects:
Online Access:https://www.mdpi.com/2076-3921/12/12/2100
_version_ 1797382267296808960
author Ying Tian
Xinyu Hong
Yuan Xie
Zaixin Guo
Qi Yu
author_facet Ying Tian
Xinyu Hong
Yuan Xie
Zaixin Guo
Qi Yu
author_sort Ying Tian
collection DOAJ
description Premature menopause is associated with an increased prevalence of nonalcoholic fatty liver disease (NAFLD). Menopausal hormone therapy (MHT) has been widely used in clinical practice and has the potential to protect mitochondrial function and alleviate NAFLD. After bilateral oophorectomy (OVX), female rats without 17β-estradiol (E<sub>2</sub>) intervention developed NAFLD, whereas E<sub>2</sub> supplementation was effective in preventing NAFLD in female rats. The altered pathways and cellular events from both comparison pairs, namely, the OVX vs. sham group and the OVX vs. E<sub>2</sub> group, were assessed using transcriptomic analysis. KEGG pathways enriched by both transcriptomic and metabolomic analyses strongly suggest that oxidative phosphorylation is a vital pathway that changes during the development of NAFLD and remains unchanged when E<sub>2</sub> is applied. Liver tissue from the OVX-induced NAFLD group exhibited increased lipid peroxidation, impaired mitochondria, and downregulated ERα/SIRT1/PGC-1α expression. An in vitro study indicated that the protective effect of E<sub>2</sub> treatment on hepatic steatosis could be abolished when ERα or SIRT1 was selectively inhibited. This damage was accompanied by reduced mitochondrial complex activity and increased lipid peroxidation. The current research indicates that E<sub>2</sub> upregulates the ERα/SIRT1/PGC-1α signaling pathway and protects mitochondrial function to prevent OVX-induced NAFLD.
first_indexed 2024-03-08T21:02:58Z
format Article
id doaj.art-d343eb4d54794f4891faaae47fec716e
institution Directory Open Access Journal
issn 2076-3921
language English
last_indexed 2024-03-08T21:02:58Z
publishDate 2023-12-01
publisher MDPI AG
record_format Article
series Antioxidants
spelling doaj.art-d343eb4d54794f4891faaae47fec716e2023-12-22T13:48:32ZengMDPI AGAntioxidants2076-39212023-12-011212210010.3390/antiox1212210017β-Estradiol (E<sub>2</sub>) Upregulates the ERα/SIRT1/PGC-1α Signaling Pathway and Protects Mitochondrial Function to Prevent Bilateral Oophorectomy (OVX)-Induced Nonalcoholic Fatty Liver Disease (NAFLD)Ying Tian0Xinyu Hong1Yuan Xie2Zaixin Guo3Qi Yu4Department of Obstetrics and Gynecology, National Clinical Research Center for Obstetric & Gynecologic Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Peking Union Medical College Hospital (Dongdan Campus), No.1 Shuaifuyuan Wangfujing Dongcheng District, Beijing 100730, ChinaDepartment of Obstetrics and Gynecology, National Clinical Research Center for Obstetric & Gynecologic Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Peking Union Medical College Hospital (Dongdan Campus), No.1 Shuaifuyuan Wangfujing Dongcheng District, Beijing 100730, ChinaDepartment of Obstetrics and Gynecology, National Clinical Research Center for Obstetric & Gynecologic Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Peking Union Medical College Hospital (Dongdan Campus), No.1 Shuaifuyuan Wangfujing Dongcheng District, Beijing 100730, ChinaDepartment of Obstetrics and Gynecology, National Clinical Research Center for Obstetric & Gynecologic Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Peking Union Medical College Hospital (Dongdan Campus), No.1 Shuaifuyuan Wangfujing Dongcheng District, Beijing 100730, ChinaDepartment of Obstetrics and Gynecology, National Clinical Research Center for Obstetric & Gynecologic Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Peking Union Medical College Hospital (Dongdan Campus), No.1 Shuaifuyuan Wangfujing Dongcheng District, Beijing 100730, ChinaPremature menopause is associated with an increased prevalence of nonalcoholic fatty liver disease (NAFLD). Menopausal hormone therapy (MHT) has been widely used in clinical practice and has the potential to protect mitochondrial function and alleviate NAFLD. After bilateral oophorectomy (OVX), female rats without 17β-estradiol (E<sub>2</sub>) intervention developed NAFLD, whereas E<sub>2</sub> supplementation was effective in preventing NAFLD in female rats. The altered pathways and cellular events from both comparison pairs, namely, the OVX vs. sham group and the OVX vs. E<sub>2</sub> group, were assessed using transcriptomic analysis. KEGG pathways enriched by both transcriptomic and metabolomic analyses strongly suggest that oxidative phosphorylation is a vital pathway that changes during the development of NAFLD and remains unchanged when E<sub>2</sub> is applied. Liver tissue from the OVX-induced NAFLD group exhibited increased lipid peroxidation, impaired mitochondria, and downregulated ERα/SIRT1/PGC-1α expression. An in vitro study indicated that the protective effect of E<sub>2</sub> treatment on hepatic steatosis could be abolished when ERα or SIRT1 was selectively inhibited. This damage was accompanied by reduced mitochondrial complex activity and increased lipid peroxidation. The current research indicates that E<sub>2</sub> upregulates the ERα/SIRT1/PGC-1α signaling pathway and protects mitochondrial function to prevent OVX-induced NAFLD.https://www.mdpi.com/2076-3921/12/12/2100surgical menopausenonalcoholic fatty liver diseasemenopausal hormone therapymitochondriaoxidative stress
spellingShingle Ying Tian
Xinyu Hong
Yuan Xie
Zaixin Guo
Qi Yu
17β-Estradiol (E<sub>2</sub>) Upregulates the ERα/SIRT1/PGC-1α Signaling Pathway and Protects Mitochondrial Function to Prevent Bilateral Oophorectomy (OVX)-Induced Nonalcoholic Fatty Liver Disease (NAFLD)
Antioxidants
surgical menopause
nonalcoholic fatty liver disease
menopausal hormone therapy
mitochondria
oxidative stress
title 17β-Estradiol (E<sub>2</sub>) Upregulates the ERα/SIRT1/PGC-1α Signaling Pathway and Protects Mitochondrial Function to Prevent Bilateral Oophorectomy (OVX)-Induced Nonalcoholic Fatty Liver Disease (NAFLD)
title_full 17β-Estradiol (E<sub>2</sub>) Upregulates the ERα/SIRT1/PGC-1α Signaling Pathway and Protects Mitochondrial Function to Prevent Bilateral Oophorectomy (OVX)-Induced Nonalcoholic Fatty Liver Disease (NAFLD)
title_fullStr 17β-Estradiol (E<sub>2</sub>) Upregulates the ERα/SIRT1/PGC-1α Signaling Pathway and Protects Mitochondrial Function to Prevent Bilateral Oophorectomy (OVX)-Induced Nonalcoholic Fatty Liver Disease (NAFLD)
title_full_unstemmed 17β-Estradiol (E<sub>2</sub>) Upregulates the ERα/SIRT1/PGC-1α Signaling Pathway and Protects Mitochondrial Function to Prevent Bilateral Oophorectomy (OVX)-Induced Nonalcoholic Fatty Liver Disease (NAFLD)
title_short 17β-Estradiol (E<sub>2</sub>) Upregulates the ERα/SIRT1/PGC-1α Signaling Pathway and Protects Mitochondrial Function to Prevent Bilateral Oophorectomy (OVX)-Induced Nonalcoholic Fatty Liver Disease (NAFLD)
title_sort 17β estradiol e sub 2 sub upregulates the erα sirt1 pgc 1α signaling pathway and protects mitochondrial function to prevent bilateral oophorectomy ovx induced nonalcoholic fatty liver disease nafld
topic surgical menopause
nonalcoholic fatty liver disease
menopausal hormone therapy
mitochondria
oxidative stress
url https://www.mdpi.com/2076-3921/12/12/2100
work_keys_str_mv AT yingtian 17bestradiolesub2subupregulatestheerasirt1pgc1asignalingpathwayandprotectsmitochondrialfunctiontopreventbilateraloophorectomyovxinducednonalcoholicfattyliverdiseasenafld
AT xinyuhong 17bestradiolesub2subupregulatestheerasirt1pgc1asignalingpathwayandprotectsmitochondrialfunctiontopreventbilateraloophorectomyovxinducednonalcoholicfattyliverdiseasenafld
AT yuanxie 17bestradiolesub2subupregulatestheerasirt1pgc1asignalingpathwayandprotectsmitochondrialfunctiontopreventbilateraloophorectomyovxinducednonalcoholicfattyliverdiseasenafld
AT zaixinguo 17bestradiolesub2subupregulatestheerasirt1pgc1asignalingpathwayandprotectsmitochondrialfunctiontopreventbilateraloophorectomyovxinducednonalcoholicfattyliverdiseasenafld
AT qiyu 17bestradiolesub2subupregulatestheerasirt1pgc1asignalingpathwayandprotectsmitochondrialfunctiontopreventbilateraloophorectomyovxinducednonalcoholicfattyliverdiseasenafld